Management of patients with ST-segment myocardial infarction and multivessel disease: what are the options in 2022?
Journal
Coronary artery disease
ISSN: 1473-5830
Titre abrégé: Coron Artery Dis
Pays: England
ID NLM: 9011445
Informations de publication
Date de publication:
01 09 2022
01 09 2022
Historique:
pubmed:
12
7
2022
medline:
3
8
2022
entrez:
11
7
2022
Statut:
ppublish
Résumé
Multivessel coronary disease is a frequent finding in patients with STEMI. However, choosing the optimal treatment strategy for these patients can be challenging. The benefit of complete versus culprit-vessel-only revascularization demonstrated by several studies led to a change in the current 2018 ESC/EACTS revascularization guidelines recommending treatment of nonculprit lesions before hospital discharge. This article summarizes current data in this area, looks at remaining knowledge gaps and gives an outlook regarding ongoing trials. The latter will provide further robust evidence for the optimal management of patients with STEMI and multivessel disease.
Identifiants
pubmed: 35811565
doi: 10.1097/MCA.0000000000001157
pii: 00019501-202209000-00008
doi:
Banques de données
ClinicalTrials.gov
['NCT03298659', 'NCT02862119']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
485-489Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Références
Windecker S, Kolh P, Alfonso F, Collet J-P, Cremer J, Falk V, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35:2541–2619.
Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O’Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000; 343:915–922.
Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J 2007; 28:1709–1716.
Gershlick AH. STEMI - are we there yet? EuroIntervention 2018; 13:1869–1873.
Kornowski R, Mehran R, Dangas G, Nikolsky E, Assali A, Claessen BE, et al.; HORIZONS-AMI Trial Investigators. Prognostic impact of staged versus “one-time” multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J Am Coll Cardiol 2011; 58:704–711.
Hannan EL, Samadashvili Z, Walford G, Holmes DR Jr, Jacobs AK, Stamato NJ, et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv 2010; 3:22–31.
Iqbal MB, Ilsley C, Kabir T, Smith R, Lane R, Mason M, et al.; London Heart Attack Centre (HAC) Group Investigators. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London. Circ Cardiovasc Qual Outcomes 2014; 7:936–943.
Wald DS, Morris JK, Wald NJ, Chase AJ, Edwards RJ, Hughes LO, et al.; PRAMI Investigators. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 2013; 369:1115–1123.
Gershlick AH, Khan JN, Kelly DJ, Greenwood JP, Sasikaran T, Curzen N, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol 2015; 65:963–972.
Engstrøm T, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, Holmvang L, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial. Lancet 2015; 386:665–671.
Smits PC, Abdel-Wahab M, Neumann FJ, Boxma-de Klerk BM, Lunde K, Schotborgh CE, et al.; Compare-Acute Investigators. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. N Engl J Med 2017; 376:1234–1244.
Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, et al.; COMPLETE Trial Steering Committee and Investigators. Complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med 2019; 381:1411–1421.
Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al.; ESC Scientific Document Group. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 2019; 40:87–165.
Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al.; ESC Scientific Document Group. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018; 39:119–177.
Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, et al.; CULPRIT-SHOCK Investigators. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med 2017; 377:2419–2432.
Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, et al.; STREAM Investigative Team. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2013; 368:1379–1387.
Wood DA, Cairns JA, Wang J, Mehran R, Storey RF, Nguyen H, et al.; COMPLETE Investigators. Timing of staged nonculprit artery revascularization in patients with ST-segment elevation myocardial infarction: COMPLETE trial. J Am Coll Cardiol 2019; 74:2713–2723.
Bainey KR, Engstrøm T, Smits PC, Gershlick AH, James SK, Storey RF, et al. Complete vs culprit-lesion-only revascularization for ST-segment elevation myocardial infarction: a systematic review and meta-analysis. JAMA Cardiol 2020; 5:881–888.
Ong P, Sechtem U. Controversies in the treatment of patients with STEMI and multivessel disease: is it time for PCI of all lesions? Clin Res Cardiol 2016; 105:467–470.
Weissler-Snir A, Gurevitz C, Assali A, Vaknin-Assa H, Bental T, Lador A, et al. Prognosis of STEMI patients with multi-vessel disease undergoing culprit-only PCI without significant residual ischemia on non-invasive stress testing. PLoS One 2015; 10:e0138474.
Iqbal MB, Nadra IJ, Ding L, Fung A, Aymong E, Chan AW, et al.; British Columbia Cardiac Registry Investigators. Culprit vessel versus multivessel versus in-hospital staged intervention for patients with ST-segment elevation myocardial infarction and multivessel disease: stratified analyses in high-risk patient groups and anatomic subsets of nonculprit disease. JACC Cardiovasc Interv 2017; 10:11–23.
Thim T, van der Hoeven NW, Musto C, Nijveldt R, Götberg M, Engstrøm T, et al. Evaluation and management of nonculprit lesions in STEMI. JACC Cardiovasc Interv 2020; 13:1145–1154.
Thim T, Götberg M, Fröbert O, Nijveldt R, van Royen N, Baptista SB, et al. Nonculprit stenosis evaluation using instantaneous wave-free ratio in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2017; 10:2528–2535.
Thiele H, Akin I, Sandri M, de Waha-Thiele S, Meyer-Saraei R, Fuernau G, et al.; CULPRIT-SHOCK Investigators. One-year outcomes after PCI strategies in cardiogenic shock. N Engl J Med 2018; 379:1699–1710.
Kolte D, Sardar P, Khera S, Zeymer U, Thiele H, Hochadel M, et al. Culprit vessel-only versus multivessel percutaneous coronary intervention in patients with cardiogenic shock complicating ST-segment-elevation myocardial infarction: a collaborative meta-analysis. Circ Cardiovasc Interv 2017; 10:e005582.
Douglas PS, Taylor A, Bild D, Bonow R, Greenland P, Lauer M, et al. Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. JACC Cardiovasc Imaging 2009; 2:897–907.